Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)
Clinical trial NCT01512199 · TERMINATED
Trial details
- NCT number
- NCT01512199
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2015-01-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.